Skip to main content
OpenTrials

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

387 public trials 106 recruiting studies
Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Completed

Treatment With SU11248 in Patients With Neuroendocrine Tumors

NCT00056693

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations
  • Pfizer Investigational Site Birmingham, Alabama, United States
  • Pfizer Investigational Site Birmingham, Alabama, United States
  • Pfizer Investigational Site Los Angeles, California, United States
  • Pfizer Investigational Site Los Angeles, California, United States
View Trial Details
Active, Not Recruiting

Testing the Effectiveness of an Anti-cancer Drug, Triapine, When Used With Targeted Radiation-based Treatment (Lutetium Lu 177 Dotatate), Compared to Lutetium Lu 177 Dotatate Alone for Metastatic Neuroendocrine Tumors

NCT05724108

Conditions
Metastatic Neuroendocrine Tumor, Neoplasms, Neoplasms by Histologic Type, +4 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
View all 25 locations
View Trial Details
Active, Not Recruiting

A Study of PM8002 in Combination With Chemotherapy in Patients With NEN

NCT05879055

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +4 more
Locations
  • Chongqing University Cancer Hospital Chongqing, Chongqing Municipality, China
  • Fujian Province Cancer Hospital Fuzhou, Fujian, China
  • Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China
  • The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China
View all 13 locations
View Trial Details
Active, Not Recruiting

Study Evaluating Tarlatamab in Chinese Participants With Advanced Small Cell Lung Cancer After Two or More Prior Lines of Treatment

NCT06502977

Conditions
Extensive Stage Small Cell Lung Cancer, Neoplasms, Neoplasms by Histologic Type, +4 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • The Second Affiliated Hospital of Army Medical University, People's Liberation Army Chongqing, Chongqing Municipality, China
  • Army Special Medical Center of Peoples Liberation Army Chongqing, Chongqing Municipality, China
  • Mengchao Hepatobiliary Hospital of Fujian Medical University Fuzhou, Fujian, China
View Trial Details
Active, Not Recruiting

Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors

NCT03375320

Conditions
Adenoma, Adenoma, Islet Cell, Digestive System Diseases, +42 more
Locations
  • Katmai Oncology Group Anchorage, Alaska, United States
  • Kingman Regional Medical Center Kingman, Arizona, United States
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
View all 433 locations
View Trial Details

Related conditions